Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients. Issue 3 (12th July 2022)

• Record Type: Journal Article
• Authors: Giri, Prashant S.; Bharti, Ankit H.; Begum, Rasheedunnisa; Dwivedi, Mitesh
• Is Part Of: Immunology. Volume 167:Issue 3(2022)
• Page Start: 314
• Page End: 327
• Publication Date: 2022-07-12
• Subjects: calcineurin -- calcium -- calmodulin -- DYRK1A -- FOXP3 -- GSK‐3β -- immune suppression -- NFATc1 -- ORAI1 -- regulatory T‐cells (Tregs); Immunology -- Periodicals
• DOI: 10.1111/imm.13538
• Languages: English
• ISSNs: 0019-2805

Abstract

Abstract: NFATs and FOXP3 are linked with impaired regulatory T‐cells (Tregs) in generalized vitiligo (GV). To elucidate calcium mediated NFATc1 signalling pathway and its effect on Treg suppressive capacity in GV. Calcium levels, calcineurin, NFATc1 and GSK‐3β activity and cell proliferation were assessed in 52 GV patients and 50 controls by calcium assay kit, calcineurin phosphatase assay kit, TransAM NFATc1 kit, GSK‐3β ELISA and BrdU cell proliferation assay. Transcripts ( CNB, CAM, GSK3B, DYRK1A and calcium channel genes) and protein (IFN‐γ, IL‐10 and TGF‐β) expressions were assessed by qPCR and ELISA, respectively. Reduced plasma and intracellular Tregs calcium levels and ORAI1 transcripts suggested altered calcium homeostasis in GV Tregs ( p = 0.00387, p = 0.0048, p < 0.0001), which led to decreased calcineurin and NFATc1 activity in GV Tregs ( p = 0.0299, p < 0.0001). CNB and CAM transcripts were reduced in GV Tregs ( p < 0.0001, p = 0.0004). GSK‐3β activity, GSK3B and DYRK1A transcripts significantly increased in GV Tregs ( p = 0.0134, p < 0.0001 and p < 0.0001). Plasma ( p = 0.0225, p = 0.032) and intracellular Treg ( p = 0.0035, p = 0.005) calcium levels, calcineurin ( p = 0.001) and NFATc1 ( p = 0.001, p < 0.0001) activity and ORAI1 ( p = 0.0093, p < 0.0001), CAM and CNB ( p = 0.0214) transcripts significantly decreased in active vitiligo (AV) and severe GV (sGV) Tregs. Calcium treatment significantly increased intracellular calcium and ORAI1 transcripts in GV Tregs ( p = 0.0042, p = 0.0035). Moreover, calcium treatment enhanced calcineurin and NFATc1 activity in GV Tregs ( p = 0.0128, p < 0.0001). Remarkably, calcium treatment increased Treg mediated suppression of CD4 + and CD8 + T‐cells ( p = 0.015, p = 0.006) in GV and increased Tregs associated cytokines: IL‐10 ( p = 0.0323, p = 0.009), TGF‐β ( p = 0.0321, p = 0.01) and decreased IFN‐γ production ( p = 0.001, p = 0.016) by CD4 + and CD8 + T‐cells. Intracellular calcium levels positively correlated with calcineurin ( r = 0.83; p < 0.0001) and NFATc1 ( r = 0.61; p < 0.0001) activity, suggesting the enhanced Treg immunosuppressive capacity after calcium treatment. Our study for the first time suggests that reduced plasma calcium and ORAI1 transcripts are linked to calcium uptake defects in Tregs, which leads to reduced calcineurin and NFATc1 activation, thereby contributing to decreased Tregs immunosuppressive capacity in GV. Elevated GSK‐3β activity and GSKB and DYRK1A transcripts are involved in reduced NFATc1 activity in GV Tregs. Overall, the study suggests that calcium‐NFATc1‐signalling pathway is likely to be involved in defective Tregs function and can be implicated for development of effective Treg mediated therapeutics for GV. Abstract : Altered calcium homeostasis may be responsible for decreased Treg suppressive capacity in GV. The Treg suppressive capacity can be enhanced through modulating the calcium‐NFATc1 signalling pathway and hence, NFATc1 can be a novel target for developing Treg‐based GV therapeutics. Additionally, the role of GSK‐3β and DYRK1A in Tregs must also be explored further, as they may also serve as potential targets to increase NFATc1 activity.